title: [How I manage patients developing thromboembolic complications as a result of breast cancer treatment with tamoxifen ].
abstract: Thromboembolic complications are well known side effects of treatment with tamoxifen in patients with breast cancer. The authors review the pathophysiology and the risk factors that increase the probability to develop these complications. The most appropriate treatment is discussed.
authors.affiliation: Université de Liège.
authors.forename: D
authors.initials: D
authors.lastname: Pelerin
authors.forename: R M
authors.initials: RM
authors.lastname: Silvestre
authors.forename: G
authors.initials: G
authors.lastname: Jérusalem
authors.forename: B
authors.initials: B
authors.lastname: Sautois
authors.forename: M
authors.initials: M
authors.lastname: Polus
authors.forename: G
authors.initials: G
authors.lastname: Fillet
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012307:Risk Factors; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D013923:Thromboembolism / Q000139:chemically induced* / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D014812:Vitamin K